Related Experiment Video
Updated: Jul 6, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Serum lysozyme in inflammatory bowel disease.
Serum lysozyme activity is often normal in ulcerative colitis but may be elevated in Crohn's disease, particularly with increased disease severity. Both tested methods showed similar sensitivity for detecting these changes.
Area of Science:
- Biochemistry
- Immunology
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, involves complex immune dysregulation.
- Lysozyme, an enzyme involved in innate immunity, has been investigated as a potential biomarker in various inflammatory conditions.
Purpose of the Study:
- To evaluate and compare serum lysozyme activity in patients with ulcerative colitis and Crohn's disease.
- To assess the correlation between serum lysozyme levels and disease activity in Crohn's disease.
Main Methods:
- Serum lysozyme activity was quantified in patients using two distinct methods: turbidimetric assay and the lysoplate method.
- Patient cohorts included 18 individuals with ulcerative colitis and 40 individuals with Crohn's disease.
Main Results:
- Elevated serum lysozyme activity was infrequently observed in ulcerative colitis (1 of 18 patients).
- Increased serum lysozyme activity was detected in a subset of Crohn's disease patients (8 of 40).
- A positive correlation was noted between higher serum lysozyme levels and increased disease activity in Crohn's disease patients.
Conclusions:
- Serum lysozyme activity is not a consistently elevated marker in ulcerative colitis.
- Elevated serum lysozyme may serve as a potential indicator in Crohn's disease, correlating with disease severity.
- The turbidimetric and lysoplate methods demonstrate comparable efficacy in detecting alterations in serum lysozyme activity.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations